Literature DB >> 31171658

Ironing out pulmonary arterial hypertension.

Jodie L Babitt1.   

Abstract

Entities:  

Year:  2019        PMID： 31171658      PMCID： PMC6601273          DOI： 10.1073/pnas.1908298116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

Review 1.  Iron and oxygen sensing: a tale of 2 interacting elements?

Authors:  Robert J Simpson; Andrew T McKie
Journal:  Metallomics       Date:  2015-02       Impact factor: 4.526

2.  Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension.

Authors:  Elaine Soon; Carmen M Treacy; Mark R Toshner; Robert MacKenzie-Ross; Vijay Manglam; Mark Busbridge; Mark Sinclair-McGarvie; Jayantha Arnold; Karen K Sheares; Nicholas W Morrell; Joanna Pepke-Zaba
Journal:  Thorax       Date:  2011-02-05       Impact factor: 9.139

3.  Iron deficiency is common in idiopathic pulmonary arterial hypertension.

Authors:  G Ruiter; S Lankhorst; A Boonstra; P E Postmus; S Zweegman; N Westerhof; W J van der Laarse; A Vonk-Noordegraaf
Journal:  Eur Respir J       Date:  2010-09-30       Impact factor: 16.671

4.  Iron deficiency in patients with idiopathic pulmonary arterial hypertension.

Authors:  Vanessa P M van Empel; Joy Lee; Trevor J Williams; David M Kaye
Journal:  Heart Lung Circ       Date:  2013-09-01       Impact factor: 2.975

Review 5.  Iron homeostasis and its interaction with prolyl hydroxylases.

Authors:  David R Mole
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

6.  Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study.

Authors:  Thomas Viethen; Felix Gerhardt; Daniel Dumitrescu; Susanne Knoop-Busch; Henrik ten Freyhaus; Tanja K Rudolph; Stephan Baldus; Stephan Rosenkranz
Journal:  Int J Cardiol       Date:  2014-04-27       Impact factor: 4.164

7.  Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials.

Authors:  Thomas G Smith; Nick P Talbot; Catherine Privat; Maria Rivera-Ch; Annabel H Nickol; Peter J Ratcliffe; Keith L Dorrington; Fabiola León-Velarde; Peter A Robbins
Journal:  JAMA       Date:  2009-10-07       Impact factor: 56.272

8.  Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights.

Authors:  Christopher J Rhodes; Luke S Howard; Mark Busbridge; Damien Ashby; Eumorfia Kondili; J Simon R Gibbs; John Wharton; Martin R Wilkins
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

9.  Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function.

Authors:  Samira Lakhal-Littleton; Magda Wolna; Carolyn A Carr; Jack J J Miller; Helen C Christian; Vicky Ball; Ana Santos; Rebeca Diaz; Daniel Biggs; Richard Stillion; Philip Holdship; Fiona Larner; Damian J Tyler; Kieran Clarke; Benjamin Davies; Peter A Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-23       Impact factor: 11.205

10.  The increase in pulmonary arterial pressure caused by hypoxia depends on iron status.

Authors:  Thomas G Smith; George M Balanos; Quentin P P Croft; Nick P Talbot; Keith L Dorrington; Peter J Ratcliffe; Peter A Robbins
Journal:  J Physiol       Date:  2008-10-27       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.